Table 2 Disease distribution and Clinical results
From: Clinical relevance of "withdrawal therapy" as a form of hormonal manipulation for breast cancer
Patients (n) | Disease type | CB = n (%) | DoCB in months | DoT in months |
|---|---|---|---|---|
All (n = 17) | 14 MBC 3 LAPC | 10 (58.8%); 1PR,9SD (8 MBC & 2 LAPC) | 10+ (7-27) | 9+ (1-27) |
Tamoxifen (n = 10) | 9 MBC 1 LAPC | 6 (60%); 1 PR, 5 SD (6 MBC) | 10.5+ (7-27) | 8.5+ (1-27) |
Rest (n = 7) 1M,1F,4E,1L | 5 MBC 2 LAPC | 4 (57.1%); 4 SD (2 MBC & 2 LAPC) | 9.5+ (9-23) | 9+ (2-23) |